Framingham life science consulting firm Alira Health announced Tuesday it has acquired CROS NT, a contract research organization headquartered in Italy with offices across Europe and the United States.
CROS NT provides biometrics and solutions to help clients develop and deliver therapeutics and diagnostics. The acquisition brings additional expertise to Alita Health’s advisory and implementation services.
As part of the acquisition, Paolo Morelli will join Alira Health’s leadership as executive vice president of biometrics, and will lead the growth of Alira Health’s data science services, according to the release.
CROS NT has offices in Bologna and Verona, Italy; London, England and Chapel Hill, N.C.
No information was provided about the financial terms of the acquisition.
The acquisition comes on the heels of a recent influx of $35 million to Alira from the firm of a wealthy French family.
